EVALUATION OF SYSTEMIC IMMUNE INFLAMMATION INDEX IN PATIENTS WITH PSORIASIS

Thị Phương Uyên Ngô, Thế Trung Văn

Main Article Content

Abstract

Background: Evaluation of systemic immune inflammation index in patients with psoriasis. Methods: Cross-sectional descriptive study, including 80 patients diagnosed with psoriasis aged 18 years or older treated at Ho Chi Minh City Dermatology Hospital from December 2022 to October 2023 and 40 healthy people control. Results: The SII index value did not have a statistically significant difference between the group of patients with a family history and the group of patients without a family history (p = 0,9), between the group of patients with nail damage and the group of patients without nail damage (p = 0,2). No correlation was found between SII index value and patient age (r = 0,008, p = 0,94), age of onset (r = 0,006, p = 0,94), duration of disease (r = 0,01, p = 0,94). SII index values in psoriasis patients and PASI index have a moderate positive correlation (r = 0.4834, p < 0.001). The SII index value correlated weakly with hs-CRP concentration (r = 0,2507, p < 0,05) and erythrocyte sedimentation rate (r = 0,2411, p = 0,03). The SII index value has a strong positive correlation with both NLR (r = 0,908) and PLR (r = 0,7691) indexes. Conclusion: The systemic immunoinflammatory index was found to be significantly higher in patients with psoriasis than in healthy subjects. Systemic immune inflammation index can serve as an supporting method in the clinical diagnosis of psoriasis.

Article Details

References

1. Gudjonsson JE, Karason A, Runarsdottir EH, et al. Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients--an analysis of 1019 HLA-C- and HLA-B-typed patients. J Invest Dermatol. 2006;126(4):740-745. doi:10.1038/sj.jid.5700118
2. Spolverato G, Maqsood H, Kim Y, et al. Neutrophil-lymphocyte and platelet-lymphocyte ratio in patients after resection for hepato-pancreatico-biliary malignancies. J Surg Oncol. 2015;111(7):868-874. doi:10.1002/jso.23900
3. Hu B, Yang XR, Xu Y, et al. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212-6222. doi:10.1158/1078-0432.CCR-14-0442
4. Ye Z, Hu T, Wang J, et al. Systemic immune-inflammation index as a potential biomarker of cardiovascular diseases: A systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:933913. doi:10.3389/fcvm.2022.933913
5. Department of Dermatology, Ataturk University, School of Medicine, Erzurum, Turkiye, Melikoglu M, Pala E,. Systemic Immune-Inflammation Index as a Biomarker of Psoriasis Severity. Arch Basic Clin Res. Published online April 24, 2023. doi:10.5152/ ABCR.2023.22124
6. Yorulmaz A, Hayran Y, Akpinar U, Yalcin B. Systemic Immune-Inflammation Index (SII) Predicts Increased Severity in Psoriasis and Psoriatic Arthritis. Curr Health Sci J. 2020;46(4):352-357. doi:10.12865/CHSJ.46.04.05
7. Dincer Rota D, Tanacan E. The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis. Int J Clin Pract. 2021;75(6):e14101. doi:10.1111/ijcp.14101
8. Albayrak H. Neutrophil-to-Lymphocyte Ratio, Neutrophil-to-Monocyte Ratio, Platelet-to-Lymphocyte Ratio, and Systemic Immune-Inflammation Index in Psoriasis Patients: Response to Treatment with Biological Drugs. Journal of Clinical Medicine. 2023;12(17):5452. doi:10.3390/jcm12175452
9. Sugimoto E, Matsuda H, Shibata S, et al. Impact of Pretreatment Systemic Inflammatory Markers on Treatment Persistence with Biologics and Conventional Systemic Therapy: A Retrospective Study of Patients with Psoriasis Vulgaris and Psoriatic Arthritis. Journal of Clinical Medicine. 2023;12(8):3046. doi:10.3390/ jcm12083046